ALRT-1109

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameALRT-1109
Drug Alias Nameretinoic acid receptor antagonists (Allergan/Ligand)RAR antagonists (Allergan/Ligand)ALRT-1109
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors inhibitors
TargetsRetinoic acid receptors
Therapy Area/IndicationsSkin Diseases +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Ligand Retinoid Therapeutics IncLigand Pharmaceuticals IncVitae Pharmaceuticals Inc +[4] 
Active IndicationsN/A
Inactive IndicationsSkin Diseases +[2] 

Other Information

ATC CodeN/A
Related LinksN/A